India’s Rising Bioeconomy

 

1. India’s bioeconomy grew from USD 10 billion in 2014 to USD 165.7 billion in 2024, contributing 4.25 percent to national Gross Domestic Product (GDP) and targeting USD 300 billion by 2030.

2. Four major subsectors drove the 2024 bioeconomy: BioIndustrial at USD 78.2 billion or 47 percent, BioPharma at USD 58.4 billion or 35.2 percent in total value terms nationally.

3. BioAgri contributed USD 13.5 billion, or 8.1 percent, while BioResearch and Bio Information Technology (BioIT) together reached USD 15.6 billion, or 9.4 percent, in India’s 2024 bioeconomy within the sector overall.

4. Maharashtra led India’s bioeconomy in 2024 with USD 35.45 billion, followed by Karnataka at USD 32.4 billion and Telangana at USD 19.9 billion value among all states that year.

5. Southern India contributed 45.4 percent of the national bioeconomy in 2024, valued at USD 75.2 billion, while the western region accounted for USD 50.2 billion during the year.

6. India achieved 20 percent ethanol blending in petrol in 2025, five years ahead of target, rising from 1.5 percent in 2014 through sustained reforms nationwide and investment support.

7. Between Ethanol Supply Year (ESY) 2014-15 and June 2025, farmers received ₹1,21,000 crore for ethanol feedstock, while 20 percent blending alone can generate ₹40,000 crore annual payments for farmers.

8. Till July 2025, ethanol blending replaced 245 lakh metric tonnes of crude oil imports and saved ₹1,44,087 crore in foreign exchange, significantly strengthening India’s energy independence goals nationally.

9. India has become a global vaccine manufacturing hub, with Serum Institute’s non-COVID market share rising from 19 percent in 2021 to 24 percent in 2024 worldwide supply leadership.

10. Three Indian companies, Serum Institute, Bharat Biotech, and Biological E, are among ten manufacturers supplying over 80 percent of global vaccines in concentrated markets as of 2024 globally.

11. Indian firms supplied 40 percent of World Health Organization vaccine purchases, and about 20 percent of India’s vaccine exports went to the World Health Organization African Region alone.

12. The BioE3 Policy (Biotechnology for Economy, Environment and Employment), approved on 24 August 2024, is India’s first biotechnology policy focused on high-performance biomanufacturing, regenerative practices, and the Biomanufacturing and Biofoundry Initiative for national growth.

13. In August 2025, the government launched the BioE3 Challenge for Youth and India’s first National Biofoundry Network to expand biotechnology innovation, employment, and sustainability through youth-led solutions nationally.

14. Starting October 2025, the BioE3 Challenge offers ten monthly prizes of ₹1 lakh each, while 100 participants can receive up to ₹25 lakh proof-of-concept support through Biotechnology Industry Research Assistance Council funding.

15. India’s biotech startup ecosystem expanded from 5,365 startups in 2021 to 13,000 in 2025, with over 800 products developed and USD 600 million follow-on funding raised by startups.

Must Know Terms :

 

1.BioE3

BioE3 stands for Biotechnology for Economy, Environment and Employment. Approved on 24 August 2024, it is India’s first dedicated biotechnology policy focused on high-performance biomanufacturing. It promotes regenerative and sustainable production systems instead of purely consumptive industrial models. The policy also supports the Biomanufacturing and Biofoundry Initiative, linking biotechnology with green growth, industrial scale-up, employment generation, and innovation.

2.Biofoundry

A biofoundry is an advanced facility that uses automation, engineering biology, and high-throughput experimentation to design, build, and test biological systems faster. India launched its first National Biofoundry Network in August 2025 to strengthen biotechnology innovation. Biofoundries are important because they help startups, researchers, and industries develop scalable biological products in areas such as health, agriculture, food, and sustainable manufacturing.

3.BioIndustrial

BioIndustrial is the largest segment of India’s bioeconomy, valued at USD 78.2 billion in 2024 and accounting for about 47 percent of the total sector. It includes biofuels, bio-based chemicals, bioplastics, enzymes, and industrial biological processes. This segment is important because it supports green manufacturing, reduces fossil dependence, and connects biotechnology directly with sustainability, circular economy goals, and industrial transformation.

4.BioAgri

BioAgri is the agricultural biotechnology segment of India’s bioeconomy and was valued at USD 13.5 billion in 2024, contributing 8.1 percent to the total. It covers genetically modified crops, precision farming, and bio-based agricultural products. Its significance lies in improving crop productivity, supporting sustainability, and linking scientific innovation with farm output, food systems, and long-term rural economic resilience in India.

5.ESY

ESY means Ethanol Supply Year, the period used for tracking ethanol procurement and blending outcomes in India’s fuel programme. Between ESY 2014-15 and June 2025, farmers received ₹1,21,000 crore for ethanol feedstock. This term is important because ethanol blending has become a major link between agriculture, energy security, farmer income, foreign exchange savings, and the wider growth of India’s bioeconomy.

6.Biological E

Biological E is one of India’s major vaccine manufacturers and is counted among the ten companies supplying over 80 percent of global vaccines in concentrated international markets. Along with Serum Institute and Bharat Biotech, it reflects India’s growing strength in biopharmaceutical production. Its importance lies in vaccine manufacturing capacity, global health supply chains, and India’s expanding role in the bioeconomy.

Key takeaways

 

a) India’s bioeconomy grew from USD 10 bn (2014) to USD 165.7 bn (2024), targeting USD 300 bnby 2030.

b) Four key subsectors: BioIndustrial (47%), BioPharma (35%), BioAgri (8%), and BioResearch (9%).

c) Achieved 20% ethanol blending in 2025, five years ahead of target, boosting farmer income and forex savings.

d) India is a global vaccine hub, with Serum Institute’s share rising to 24% in 2024.

MCQ :

1. India’s bioeconomy grew from USD 10 billion in 2014 to what level in 2024?
A) USD 145.7 billion
B) USD 165.7 billion
C) USD 125.7 billion
D) USD 185.7 billion

2. India’s bioeconomy is targeting what value by 2030?
A) USD 350 billion
B) USD 250 billion
C) USD 400 billion
D) USD 300 billion

3. Which subsector held the largest share in India’s 2024 bioeconomy?
A) BioAgri
B) BioResearch and BioIT
C) BioPharma
D) BioIndustrial

4. The BioIndustrial segment was valued at:
A) USD 58.4 billion
B) USD 68.2 billion
C) USD 88.2 billion
D) USD 78.2 billion

5. BioPharma accounted for what share of India’s 2024 bioeconomy?
A) 55.2 percent
B) 25.2 percent
C) 35.2 percent
D) 45.2 percent

6. BioAgri contributed what value to India’s bioeconomy in 2024?
A) USD 14.5 billion
B) USD 13.5 billion
C) USD 12.5 billion
D) USD 11.5 billion

7. Which state led India’s bioeconomy in 2024?
A) Telangana
B) Gujarat
C) Maharashtra
D) Karnataka

8. Southern India contributed what share of the national bioeconomy in 2024?
A) 50.4 percent
B) 35.4 percent
C) 40.4 percent
D) 45.4 percent

9. India achieved what level of ethanol blending in petrol in 2025?
A) 18 percent
B) 20 percent
C) 15 percent
D) 10 percent

10. Between Ethanol Supply Year 2014-15 and June 2025, farmers received how much for ethanol feedstock?
A) ₹1,21,000 crore
B) ₹1,11,000 crore
C) ₹1,01,000 crore
D) ₹91,000 crore

11. Till July 2025, ethanol blending replaced how many lakh metric tonnes of crude oil imports?
A) 195 lakh metric tonnes
B) 145 lakh metric tonnes
C) 295 lakh metric tonnes
D) 245 lakh metric tonnes

12. Serum Institute’s non-COVID global vaccine market share rose to what level in 2024?
A) 20 percent
B) 22 percent
C) 26 percent
D) 24 percent

13. The BioE3 Policy was approved on:
A) 24 August 2024
B) 25 August 2024
C) 25 August 2025
D) 24 August 2023

14. Starting October 2025, how many best entries each month receive a cash prize of ₹1 lakh under the BioE3 Challenge?
A) 15
B) 20
C) 10
D) 5

15. India’s biotech startup ecosystem expanded to how many startups in 2025?
A) 15,000
B) 13,000
C) 11,000
D) 9,000